+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Analgesics in Canada

  • ID: 4420029
  • Report
  • November 2020
  • Region: Canada
  • 28 Pages
  • Euromonitor International
COVID-19 had a strong impact in the first quarter of the year due to stockpiling and demand for products to treat cold/flu and COVID-19 symptoms. Growth is also expected as the cold/flu season returns in October and consumers will be more concerned over health and wellness and in dealing with cold/flu symptoms due to worries over COVID-19. The pandemic increased supply as manufacturers ran at maximum capacity to meet demand and shifted capacity to ensure the supply of high demand products.

The Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Note: Product cover images may vary from those shown
KEY DATA FINDINGS

2020 IMPACT
  • Demand for analgesics supported by stockpiling in response to COVID-19
  • Consumers shift towards e-commerce in response to COVID-19
  • Multinationals leverage extensive distribution and product ranges to lead sales
RECOVERY AND OPPORTUNITIES
  • Ageing population supporting demand for analgesics
  • Strong growth potential within topical analgesics/anaesthetics
  • Interest in cannabis-based analgesics continues to rise
CATEGORY DATA
  • Table 1 Sales of Analgesics by Category: Value 2015-2020
  • Table 2 Sales of Analgesics by Category: % Value Growth 2015-2020
  • Table 3 NBO Company Shares of Analgesics: % Value 2016-2020
  • Table 4 LBN Brand Shares of Analgesics: % Value 2017-2020
  • Table 5 Forecast Sales of Analgesics by Category: Value 2020-2025
  • Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
EXECUTIVE SUMMARY
  • COVID-19 impact on consumer health
  • COVID-19 country impact
  • Company response
  • Retailing shift
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
  • Table 8 Life Expectancy at Birth 2015-2020
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2015-2020
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2015-2020
  • Table 11 NBO Company Shares of Consumer Health: % Value 2016-2020
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2017-2020
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
  • Table 14 Distribution of Consumer Health by Format: % Value 2015-2020
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2020
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2020-2025
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
GLOBAL MACROECONOMIC ENVIRONMENT

GLOBAL INDUSTRY ENVIRONMENT

DISCLAIMER

DEFINITIONS

SOURCES
  • Summary 1 Research Sources
Note: Product cover images may vary from those shown
Adroll
adroll